Khiron Life Sciences Corp.: Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") aloneTotal untapped potential for cannabis patients in the UK exceeds 1M patientsSupported

Related Keywords

Mexico ,Germany ,United States ,United Kingdom ,Brazil ,Colombia ,Peru ,Toronto ,Ontario ,Canada ,America ,Paola Ricardo ,Franziska Katterbach ,Khiron Europe ,Alvaro Torres ,Linkedin ,Latam Communications ,Prnewswire Khiron Life Sciences Corp ,Regulation Services Provider ,Khiron Life Sciences Corp ,Europe Communications ,Life Sciences ,Latin America ,European Zerenia Medical Cannabis Clinics ,Chief Executive Officer ,Although Khiron ,Annual Information Form ,Media Contact ,Carolina Gomez ,Peter Leis ,Khiron ,Life ,Ciences ,Orp ,Chieves ,United ,Kingdom ,Cannabis ,Sales ,Volume ,Growth ,022 ,